FOSUN HEALTH Logo

Hemifacial Spasm Treatment

catalogue

Hemifacial Spasm Treatment

Hemifacial Spasm Treatment

There are two treatments for hemifacial spasm, and they are not two versions of the same thing . Botulinum toxin treats the movement : it weakens the muscles that are being driven, its effect is measured in months, and it is repeated indefinitely. Microvascular decompression treats the cause : it moves the vessel off the nerve, it is a single operation requiring general anaesthesia and a hospital stay, and it carries its own risks. The choice between them is made on what the spasm costs a person in their working and social life rather than on how forceful it looks — which is why a mild spasm in someone who presents for a living is often a stronger case than a dramatic one in someone who works alone. This page sets out the decision itself, each of the two treatments, how the choice is actually made, what recovery involves, and what happens if the spasm returns.

Whether to treat it at all

Treating hemifacial spasm is optional, and saying that first is not a formality. Nothing about the condition requires intervention: it is not dangerous, it does not threaten anything else, and leaving it alone is a defensible decision for a spasm that is understood, infrequent and costs a person little.

What makes it worth treating is the cost rather than the severity. The question that actually decides it is not how forceful the movement is but what it takes away: a person who presents for a living, who has stopped taking meetings, who has begun to avoid video calls, or whose eye is held partly shut long enough to affect reading and driving, has a case for treatment that a severity score would not capture. A person with a forceful spasm who works alone and is unbothered by it does not.

Two things are worth separating here, because they are the reason people arrive years late. The first is that an explanation is a treatment. Being told what this is, that it is not dangerous, that it is not stress, and that two treatments exist if it is wanted, is a real outcome of an assessment — and for a proportion of people it is the whole of what they came for. The second is that waiting for it to get worse is not a plan. It does not get better on its own, and the cost accrues in the meantime.

Where the decision is to treat, the next question is which of the two, and that is what the rest of this page is about. What the spasm costs across a day is set out on the symptoms page.

Botulinum toxin: treating the movement

The injection treats the movement rather than the cause. It works by weakening, temporarily, the muscles the nerve is driving, and it is put into a small number of specific points on the affected side. It does not touch the nerve, it does not remove the vessel, and nothing about it changes the underlying condition. What it does is stop the visible movement for a period, and that period is the whole of its design.

How a session goes. It is done in the clinic, it takes minutes, and it does not require anaesthesia or a hospital stay. The points are chosen from the pattern of the individual person's spasm rather than from a fixed map — which muscles are involved, and in which order — and the dose is chosen deliberately rather than by default.

What to expect afterwards. The effect is not immediate: it builds over the first days and settles by about two weeks. What a person notices first is that the spasm is quieter rather than absent, and the first treatment is judged at review rather than repeated on a fixed schedule. The benefit then holds for a period measured in months and fades gradually as the movement returns, at which point the next treatment is given.

What can go wrong, said plainly. The injection works by weakening a muscle, and where that weakening extends further than intended the result is a temporary droop or asymmetry around the mouth or the eye on that side. It settles as the effect wears off, in the same months-long timescale as the benefit. Where the eye is being held shut by the spasm, the injection can leave it dry, which is managed rather than tolerated. Both are dose and placement issues, and both are the reason the first cycle is reviewed rather than simply repeated.

What the injection is not is a lesser option. For a large proportion of people it is the whole of the treatment for many years, and it is the one that does not require an operation to discuss. Whether a vessel has been demonstrated, which is part of what makes the other track worth raising, is covered on the diagnosis page.

Microvascular decompression: treating the cause

Microvascular decompression is the treatment that addresses the mechanism rather than the movement. The operation is performed behind the ear on the affected side, under general anaesthesia. A small opening is made in the skull, the facial nerve is identified where it leaves the brainstem, and the vessel lying against it is moved off and held away with a small spacer. Nothing is removed, and the nerve is left intact.

What it involves. It requires general anaesthesia and a hospital stay, both of which are part of the decision rather than details of it. The recovery is set out below. It is a single intervention rather than a cycle, and for many people the point of it is exactly that: the injections stop.

What it carries. It is an operation in the posterior fossa, and it carries the risks that operations in that region carry. The one named most often is a change in hearing on the operated side. Others are leakage of the fluid around the brain, infection, and an effect on the facial nerve itself, which can produce weakness on that side. Alongside those are the small risks that general anaesthesia and surgery carry anywhere. These are written out rather than summarised before anything is arranged, and they are the reason the decision is made on what the spasm costs rather than on how it looks.

What must be said about it here. It belongs in this pathway at a specific point, and we name it with that place rather than as a promise. Anything recommended that is not carried out within this pathway is named at the outset, before any payment is discussed — not at the end of a workup. That is the standard applied to every procedure discussed on this site, and it is applied here because this one is an operation rather than an injection.

What it does not guarantee. It is not a guarantee that the spasm never returns, and it is not a treatment that every person with this condition should want. Where it settles the spasm, the effect is on the mechanism rather than on the muscle, and that is the whole of the difference between the two tracks.

How the choice is actually made

The choice is not made by comparing success rates, and it is worth saying why that framing misleads. The two treatments are addressing different things — one the movement, one the mechanism — and their outcomes are not measured on the same scale. The decision is made on four factors, and the first is not severity.

Factor What it looks like in practice
What the spasm costs in a working week Whether it is affecting the work a person does, the meetings they take, or the settings they have begun to avoid — not how forceful the movement is
Whether the eye is being held shut Function rather than appearance: reading, screen work and driving are affected, and this moves the case forward more than force does
Whether a vessel has been demonstrated Imaging that shows the vessel makes the operation a reasonable thing to discuss. Its absence does not remove the option, but it changes the conversation
How the person weighs a cycle against an operation A planned return every few months indefinitely, against a single operation with its own risks. Some people are entirely clear which they would rather; most are not, until it is put that way
Age, general health, and what an anaesthetic means for this person The operation requires general anaesthesia. That is a consideration in its own right, and it is assessed rather than assumed

What the table is meant to displace is the question people arrive with, which is usually some version of how bad is it. That question has an answer — the spasm can be graded on how often it fires and how much of the face it takes — and the answer does not decide anything. Two people with the same grade make opposite choices, and both are right.

What also should be said is that the choice is not made once. It is common for the injection to be the right answer for years and the operation to become the right answer later, when the cycle has become the burden or when the spasm has reached the point of holding the eye shut. Changing tracks is not a failure of the first decision. What this costs, and how long a stay involves, is set out on the practical questions page.

What recovery involves on each track

The two tracks have almost nothing in common on this, and the difference is a large part of what people are choosing between.

After an injection. There is no recovery. A person returns to what they were doing the same day. The effect builds over the first days and is judged at about two weeks; any asymmetry or dryness is reviewed at that point rather than waited out. The practical commitment is the cycle itself — a planned return every few months — rather than any downtime around it.

After the operation. There is a hospital stay, and it is part of the decision rather than a footnote to it. The immediate period is monitored, the wound behind the ear is reviewed, and hearing on the operated side is checked. Most people go home within days rather than weeks, and the return to ordinary activity is graded over the weeks that follow. Some have a headache at the wound site for a period, and some notice that hearing on that side is not the same as it was — which is why hearing is checked before as well as after.

What is common to both. The spasm does not always settle immediately after the operation; for some people it settles over weeks, and for a few it takes months. That is expected rather than a sign of failure, and it is the reason a review is scheduled rather than left to the person to raise. Where it has not settled after a defined interval, the question is revisited rather than waited out indefinitely.

And the honest limitation, stated here rather than discovered: follow-up by remote consultation covers the review, the judgement of whether a treatment has earned its place, and the decision about the next cycle. What it cannot do is the examination — which muscles are involved, whether there is weakness between episodes, and whether hearing has changed on that side. Those require a person in the room, and they are said to require a visit rather than implied to be possible over a call.

If the spasm returns

Return is possible on either track and it means different things on each, which is why it is worth describing both in advance rather than at the moment it happens.

After an injection, the spasm always returns. That is the design of the treatment rather than a failure of it: the effect wears off in months and the movement comes back. What is watched for over years is whether the character has changed — whether the pattern has altered, whether the other side has become involved, or whether weakness is now present between episodes. None of those is expected, and each is a reason to reassess rather than to continue the same cycle.

After the operation, return is a smaller and different question. Where the spasm comes back after a period of being settled, the first question is how long the interval was and how complete the settling was. Injections remain available and work as they did before: having had the operation does not remove the option, and the two are not mutually exclusive. What is not usually done is a second operation to the same end without revisiting the imaging first.

What return is not. It is not the condition getting worse in the way people fear, and it is not a sign that something else has begun. Hemifacial spasm does not become another disease. Where a return is accompanied by a new feature — weakness, a change in hearing, involvement of the other side, or any other neurological symptom — that is reassessment rather than return, and it is the distinction worth knowing.

What a person should leave an assessment with is the answer to a single question: what would make this worth coming back about. Where that was never written down, recurrence is discovered rather than anticipated, and that is the commonest way a treatable pattern in this group goes unmanaged. What a long-term plan looks like is set out on the living-with page.

Frequently Asked Questions

How long does an injection last, and does it keep working?

The effect of one treatment is measured in months rather than in weeks or in years, and it then wears off gradually as the movement returns. It is repeated on a cycle rather than given once, and for many people that cycle is what the treatment is: a planned return every few months, indefinitely. It does not stop working in the way some medicines do, and the interval between treatments is adjusted at review rather than fixed in advance. What it also does is keep working for the same reason it did the first time, which is why the decision about an operation is usually made years in rather than at the start.

What are the risks of the operation, in plain terms?

It is an operation behind the ear on one side, performed under general anaesthesia, and it carries the risks that any operation in that part of the skull carries. What people are told about specifically: a change in hearing on the operated side, which is the effect named most often; leakage of the fluid around the brain; infection; and a change in the facial nerve itself, which can produce weakness on that side. Any operation in this region also carries the small risks that general anaesthesia and surgery carry anywhere. These are written out rather than summarised before anything is arranged, and they are the reason the decision is made on what the spasm costs rather than on how forceful it looks.

If I have the operation, will I need injections afterwards?

Not necessarily, and for many people the point of the operation is exactly that the cycle ends. Where decompression settles the spasm, the injections stop. Where it does not fully settle it, or where the spasm returns after a period, injections remain available and work as they did before — the two are not mutually exclusive, and having had the operation does not remove the option. What is worth knowing is that the two are not competing versions of the same treatment: one addresses the mechanism and the other addresses the movement.

Is there anything I can do myself?

Yes, though it is worth being clear about what it can and cannot do. Nothing a person does themselves removes the cause. What they can do is lower the threshold at which the nerve fires, which reduces frequency and visibility: regular sleep, and protecting sleep in the days around anything demanding; breaks from sustained screen work and reading; treating dry eye where the eye is being held shut; and reducing the caffeine and alcohol that reliably make it worse for the people they affect. That is load management rather than treatment, and it is worth doing alongside either track rather than instead of one.

Find out which of the two is worth discussing, and on what grounds

Send a short note of how the spasm started and how far it has spread, a phone video recorded during an episode, a description in your own words of what it costs you in a working week, and any previous scans with their reports. Our team will return a written opinion on whether the pattern is hemifacial spasm, whether the imaging performed was the imaging that shows the relevant anatomy, and which of the two treatments is worth discussing — including the answer that neither is, yet.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*